Cargando…

A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model

Anaplastic thyroid cancer (ATC) is a malignant subtype of thyroid cancers and its mechanism of development remains inconclusive. Importantly, there is no effective strategy for treatment since ATC is not responsive to conventional therapies, including radioactive iodine therapy and thyroid-stimulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Wen-Bin, Tsai, Yuan-Chin, Chin, Li-Han, Tseng, Jen-Ho, Tang, Li-Wen, Horng, Steve, Fan, Yu-Ching, Hsu, Sung-Po
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073567/ https://www.ncbi.nlm.nih.gov/pubmed/29932104 http://dx.doi.org/10.3390/ijms19071834

Ejemplares similares

Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
por: Chin, Li-Han, et al.
Publicado: (2015)

Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
por: Chin, Li-Han, et al.
Publicado: (2017)

Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer
por: Chen, Mei-Chieh, et al.
Publicado: (2017)

Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway
por: Tsai, Jaw-Shiun, et al.
Publicado: (2014)

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
por: Fujita, Megumi, et al.
Publicado: (2017)

Effect of troglitazone on radiation sensitivity in cervix cancer cells
por: An, Zhengzhe, et al.
Publicado: (2012)

Troglitazone reverses the multiple drug resistance phenotype in cancer cells
por: Davies, Gerald F, et al.
Publicado: (2009)

Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro
por: Ye, Jinjun, et al.
Publicado: (2015)

Anaplastic Transformation of Papillary Thyroid Cancer in the Retroperitoneum
por: Solomon, James P., et al.
Publicado: (2015)

Lovastatin Modulates Glycogen Synthase Kinase-3β Pathway and Inhibits Mossy Fiber Sprouting after Pilocarpine-Induced Status Epilepticus
por: Lee, Chun-Yao, et al.
Publicado: (2012)

Preclinical Pharmacokinetics and Pharmacodynamics of Coptidis Preparation in Combination with Lovastatin in High-Fat Diet-Induced Hyperlipidemic Rats
por: Peng, Wen-Ya, et al.
Publicado: (2021)

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells
por: Wu, Di, et al.
Publicado: (2019)

Anaplastic Thyroid Cancer Successfully Treated With Radiation and Immunotherapy: A Case Report
por: Yang, Shuen-Ru, et al.
Publicado: (2021)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Phenotypic Characterization of Metastatic Anaplastic Thyroid Cancer Stem Cells
por: Li, Wen, et al.
Publicado: (2013)

Effects of Lovastatin on Brain Cancer Cells
por: Amadasu, Efosa, et al.
Publicado: (2022)

Effects of roniciclib in preclinical models of anaplastic thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors
por: Gigliotti, Casimiro Luca, et al.
Publicado: (2017)

The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
por: Mika, Justyna, et al.
Publicado: (2020)

Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy
por: Park, Hyunju, et al.
Publicado: (2016)

Lovastatin lowers the risk of breast cancer: a population-based study using logistic regression with a random effects model
por: Murakami, Rimi, et al.
Publicado: (2016)

Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
por: Zhao, Tong T., et al.
Publicado: (2010)

Risk Factors for Anaplastic Thyroid Cancer
por: Zivaljevic, V., et al.
Publicado: (2014)

Treatment Outcomes in Anaplastic Thyroid Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2019)

Anaplastic Cancer of the Thyroid: The Viper in the Pit
por: Seshadri, Krishna G.
Publicado: (2019)

Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
por: Enomoto, Keisuke, et al.
Publicado: (2021)

Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line
por: Yang, Yuh-Cheng, et al.
Publicado: (2007)

A Retrospective Review of Thiazolidinediones with Development of a Troglitazone Conversion Protocol
por: Lindsey, Cameron, et al.
Publicado: (2003)

Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies
por: Kapoor, Shailendra
Publicado: (2012)

Integrative Toxicoproteomics Implicates Impaired Mitochondrial Glutathione Import as an Off-Target Effect of Troglitazone
por: Lee, Yie Hou, et al.
Publicado: (2013)

Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer
por: Choi, Yoon Ju, et al.
Publicado: (2021)

FOXD3 regulates anaplastic thyroid cancer progression
por: Yin, Huabin, et al.
Publicado: (2017)

Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors
por: Zhu, Xuguang, et al.
Publicado: (2018)

Anticancer effects of natural phytochemicals in anaplastic thyroid cancer
por: Li, Yitian, et al.
Publicado: (2022)

Synergistic Effect of Binary Mixed-Pluronic Systems on Temperature Dependent Self-assembly Process and Drug Solubility
por: Lee, Chin-Fen, et al.
Publicado: (2018)

Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer
por: Park, Ki Cheong, et al.
Publicado: (2017)

Anaplastic thyroid cancer: multimodal treatment results
por: Aslan, Zaki Antonio Taissoun, et al.
Publicado: (2014)

Treatment outcomes of radiotherapy for anaplastic thyroid cancer
por: Park, Jong Won, et al.
Publicado: (2018)

Bilateral spontaneous pneumothoraces in anaplastic thyroid cancer
por: Kazzaz, Farah I., et al.
Publicado: (2019)

Recent advances in the management of anaplastic thyroid cancer
por: De Leo, Simone, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qguee83sh9bmmia1bq66g67fv1